Jessica Lovett explains the importance of being connected to the broader access ecosystem and how leveraging partnerships that can provide global insight and intelligence.
Jessica Lovett
Advertisement
Jessica Lovett is the VP of Commercial Strategy and Innovation at Innomar Strategies.
Articles by Jessica Lovett
Jessica Lovett discusses specialty pharma commercialization timelines, and how the Canadian market is different from the US.
Live from Asembia AXS26, Jessica Lovett explains what real world evidence and data matters most in making decisions around specialty medicines.
Advertisement
Latest Updated Articles
How Pharma Can Adjust to Global Market UncertaintyMay 13th 2026
Asembia AXS26: Jessica Lovett on the RWE That Matters MostApril 28th 2026
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FAQ: Strait of Hormuz Reopening — What It Means for Pharma Supply Chains
2
Will Shrank: The Trillion-Dollar Question Facing CGT Access
3
Why Some Employers Are Scaling Back GLP-1 Coverage in 2027
4
How Automation and AI Transform Pharmacovigilance
5